FAVALLI, ANDREA
FAVALLI, ANDREA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients.
2021 Pagani, L; Chinello, C; Mahajneh, A; Clerici, F; Panarello, G; Favalli, A; Gruarin, P; Grifantini, R; Bandera, A; Ungaro, R; Muscatello, A; Blasi, F; Gori, A; Magni, F
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients
2021 Notarbartolo, S; Ranzani, V; Bandera, A; Gruarin, P; Bevilacqua, V; Putignano, A; Gobbini, A; Galeota, E; Manara, C; Bombaci, M; Pesce, E; Zagato, E; Favalli, A; Sarnicola, M; Curti, S; Crosti, M; Martinovic, M; Fabbris, T; Marini, F; Donnici, L; Lorenzo, M; Mancino, M; Ungaro, R; Lombardi, A; Mangioni, D; Muscatello, A; Aliberti, S; Blasi, F; De Feo, T; Prati, D; Manganaro, L; Granucci, F; Lanzavecchia, A; De Francesco, R; Gori, A; Grifantini, R; Abrignani, S
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach.
2022 Pagani, L; Chinello, C; Mahajneh, A; Clerici, F; Criscuolo, L; Favalli, A; Gruarin, P; Grifantini, R; Bandera, A; Lombardi, A; Ungaro, R; Muscatello, A; Blasi, F; Gori and Fulvio Magni, A
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach
2022 Pagani, L; Chinello, C; Mahajneh, A; Clerici, F; Criscuolo, L; Capitoli, G; Risca, G; Favalli, A; Gruarin, P; Grifantini, R; Bandera, A; Lombardi, A; Ungaro, R; Muscatello, A; Blasi, F; Gori, A; Magni, F
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach
2022 Pagani, L; Chinello, C; Mahajneh, A; Clerici, F; Panarello, G; Favalli, A; Gruarin, P; Grifantini, R; Bandera, A; Ungaro, R; Muscatello, A; Blasi, F; Gori, A; Magni, F
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome
2022 Pagani, L; Chinello, C; Mahajneh, A; Clerici, F; Criscuolo, L; Favalli, A; Gruarin, P; Grifantini, R; Bandera, A; Lombardi, A; Ungaro, R; Muscatello, A; Blasi, F; Gori, A; Magni, F
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858)
2022 Favalli, E; Gobbini, A; Bombaci, M; Maioli, G; Biggioggero, M; Pesce, E; Favalli, A; Martinovic, M; Fabbris, T; Marchisio, E; Bandera, A; Gori, A; Abrignani, S; Grifantini, R; Caporali, R
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
2022 Favalli, A; Favalli, E; Gobbini, A; Zagato, E; Bombaci, M; Maioli, G; Pesce, E; Donnici, L; Gruarin, P; Biggioggero, M; Curti, S; Manganaro, L; Marchisio, E; Bevilacqua, V; Martinovic, M; Fabbris, T; Sarnicola, M; Crosti, M; Marongiu, L; Granucci, F; Notarbartolo, S; Bandera, A; Gori, A; De Francesco, R; Abrignani, S; Caporali, R; Grifantini, R
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation
2023 Pagani, L; Chinello, C; Risca, G; Capitoli, G; Criscuolo, L; Lombardi, A; Ungaro, R; Mangioni, D; Piga, I; Muscatello, A; Blasi, F; Favalli, A; Martinovic, M; Gori, A; Bandera, A; Grifantini, R; Magni, F
Immune response to SARS-CoV-2 natural infection and vaccination in healthy subjects and in immunocompromised patients
2024 Favalli, A